132 related articles for article (PubMed ID: 26412663)
1. Analytical Ultracentrifugation and Its Role in Development and Research of Therapeutical Proteins.
Liu J; Yadav S; Andya J; Demeule B; Shire SJ
Methods Enzymol; 2015; 562():441-76. PubMed ID: 26412663
[TBL] [Abstract][Full Text] [Related]
2. Detection of protein aggregates by sedimentation velocity analytical ultracentrifugation (SV-AUC): sources of variability and their relative importance.
Arthur KK; Gabrielson JP; Kendrick BS; Stoner MR
J Pharm Sci; 2009 Oct; 98(10):3522-39. PubMed ID: 19130472
[TBL] [Abstract][Full Text] [Related]
3. Analytical Ultracentrifugation as a Tool to Study Nonspecific Protein-DNA Interactions.
Yang TC; Catalano CE; Maluf NK
Methods Enzymol; 2015; 562():305-30. PubMed ID: 26412658
[TBL] [Abstract][Full Text] [Related]
4. Protein Assembly in Serum and the Differences from Assembly in Buffer.
Hill JJ; Laue TM
Methods Enzymol; 2015; 562():501-27. PubMed ID: 26412665
[TBL] [Abstract][Full Text] [Related]
5. Analysis of monoclonal antibodies by sedimentation velocity analytical ultracentrifugation.
Stine WB
Methods Mol Biol; 2013; 988():227-40. PubMed ID: 23475724
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of aggregates in therapeutic proteins using sedimentation velocity analytical ultracentrifugation: practical considerations that affect precision and accuracy.
Pekar A; Sukumar M
Anal Biochem; 2007 Aug; 367(2):225-37. PubMed ID: 17548043
[TBL] [Abstract][Full Text] [Related]
7. Ultrafiltration behavior of monoclonal antibodies and Fc-fusion proteins: Effects of physical properties.
Baek Y; Singh N; Arunkumar A; Borys M; Li ZJ; Zydney AL
Biotechnol Bioeng; 2017 Sep; 114(9):2057-2065. PubMed ID: 28464237
[TBL] [Abstract][Full Text] [Related]
8. Precision of protein aggregation measurements by sedimentation velocity analytical ultracentrifugation in biopharmaceutical applications.
Gabrielson JP; Arthur KK; Stoner MR; Winn BC; Kendrick BS; Razinkov V; Svitel J; Jiang Y; Voelker PJ; Fernandes CA; Ridgeway R
Anal Biochem; 2010 Jan; 396(2):231-41. PubMed ID: 19782040
[TBL] [Abstract][Full Text] [Related]
9. Probing reversible self-association of therapeutic proteins by sedimentation velocity in the analytical ultracentrifuge.
Perez-Ramirez B; Steckert JJ
Methods Mol Biol; 2005; 308():301-18. PubMed ID: 16082044
[No Abstract] [Full Text] [Related]
10. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
Liu J; Nguyen MD; Andya JD; Shire SJ
J Pharm Sci; 2005 Sep; 94(9):1928-40. PubMed ID: 16052543
[TBL] [Abstract][Full Text] [Related]
11. Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity.
Sinha N; Mohan S; Lipschultz CA; Smith-Gill SJ
Biophys J; 2002 Dec; 83(6):2946-68. PubMed ID: 12496069
[TBL] [Abstract][Full Text] [Related]
12. Aggregates in monoclonal antibody manufacturing processes.
Vázquez-Rey M; Lang DA
Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193
[TBL] [Abstract][Full Text] [Related]
13. Effects of rotational speed on the hydrodynamic properties of pharmaceutical antibodies measured by analytical ultracentrifugation sedimentation velocity.
Krayukhina E; Uchiyama S; Fukui K
Eur J Pharm Sci; 2012 Sep; 47(2):367-74. PubMed ID: 22728396
[TBL] [Abstract][Full Text] [Related]
14. Investigation of protein-surfactant interactions by analytical ultracentrifugation and electron paramagnetic resonance: the use of recombinant human tissue factor as an example.
Jones LS; Cipolla D; Liu J; Shire SJ; Randolph TW
Pharm Res; 1999 Jun; 16(6):808-12. PubMed ID: 10397598
[TBL] [Abstract][Full Text] [Related]
15. A case study and use of sedimentation equilibrium analytical ultracentrifugation as a tool for biopharmaceutical development.
Varley PG; Brown AJ; Dawkes HC; Burns NR
Eur Biophys J; 1997; 25(5-6):437-43. PubMed ID: 9188166
[TBL] [Abstract][Full Text] [Related]
16. Protein-protein and ligand-protein interactions studied by analytical ultracentrifugation.
Stafford WF
Methods Mol Biol; 2009; 490():83-113. PubMed ID: 19157080
[TBL] [Abstract][Full Text] [Related]
17. Association states of the transcription activator protein NtrC from E. coli determined by analytical ultracentrifugation.
Rippe K; Mücke N; Schulz A
J Mol Biol; 1998 May; 278(5):915-33. PubMed ID: 9600853
[TBL] [Abstract][Full Text] [Related]
18. Assessment and significance of protein-protein interactions during development of protein biopharmaceuticals.
Yadav S; Liu J; Scherer TM; Gokarn Y; Demeule B; Kanai S; Andya JD; Shire SJ
Biophys Rev; 2013 Jun; 5(2):121-136. PubMed ID: 28510158
[TBL] [Abstract][Full Text] [Related]
19. A therapeutic antibody and its antigen form different complexes in serum than in phosphate-buffered saline: a study by analytical ultracentrifugation.
Demeule B; Shire SJ; Liu J
Anal Biochem; 2009 May; 388(2):279-87. PubMed ID: 19289095
[TBL] [Abstract][Full Text] [Related]
20. A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies.
Esfandiary R; Hayes DB; Parupudi A; Casas-Finet J; Bai S; Samra HS; Shah AU; Sathish HA
J Pharm Sci; 2013 Sep; 102(9):3089-99. PubMed ID: 23794522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
